Niklas Schultz
Impact in
- Oncology top 0.2%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 1%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Cancer therapeutics and mechanisms
Papers in
-
- DNA Repair Mechanisms 18
- Molecular Biology Techniques and Applications 4
- Cancer therapeutics and mechanisms 4
- CRISPR and Genetic Engineering 4
- Oncology 13
- PARP inhibition in cancer therapy 10
- Co-authors
- Thomas Helleday (23 shared papers)Helen E. Bryant (6 shared papers)Mark Meuth (3 shared papers)Elena López‐Knowles (2 shared papers)Suzanne Kyle (2 shared papers)Nicola J. Curtin (2 shared papers)Huw D. Thomas (2 shared papers)Natalia Issaeva (3 shared papers)
- Journals
- Nature Communications (3 papers)Molecular and Cellular Biology (2 papers)Journal of Molecular Biology (2 papers)Nature (2 papers)The EMBO Journal (1 paper)
- Partner nations
- SwedenUnited KingdomSpain
In The Last Decade
Niklas Schultz
32 papers receiving 7.1k citations
Niklas Schultz's Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 4.3k
- Molecular Biology 5.3k
- Cancer Research 998
- Reproductive Medicine 264
- Immunology 563
Countries citing papers authored by Niklas Schultz
This map shows the geographic impact of Niklas Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Schultz more than expected).
Fields of papers citing papers by Niklas Schultz
This network shows the impact of papers produced by Niklas Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Schultz. The network helps show where Niklas Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Niklas Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Hit paper breakdown → | 2005 | 3962 |
| 2 | Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair Hit paper breakdown → | 2010 | 654 |
| 3 | 2009 | 491 | |
| 4 | Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity Hit paper breakdown → | 2018 | 374 |
| 5 | 2005 | 281 | |
| 6 | 2002 | 204 | |
| 7 | 2010 | 170 | |
| 8 | 2005 | 143 | |
| 9 | 2015 | 118 | |
| 10 | 2003 | 97 | |
| 11 | 2005 | 92 | |
| 12 | 2021 | 70 | |
| 13 | 2015 | 66 | |
| 14 | 2010 | 63 | |
| 15 | 2013 | 53 | |
| 16 | 2010 | 50 | |
| 17 | 2004 | 44 | |
| 18 | 2007 | 40 | |
| 19 | 2023 | 40 | |
| 20 | 2006 | 34 |
About Niklas Schultz
Niklas Schultz is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Cell Biology, having authored 32 papers that have together received 7.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (18 papers), PARP inhibition in cancer therapy (10 papers), Carcinogens and Genotoxicity Assessment (8 papers), Microtubule and mitosis dynamics (4 papers), Molecular Biology Techniques and Applications (4 papers), Prostate Cancer Treatment and Research (4 papers), Cancer therapeutics and mechanisms (4 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Oncology (4.3k citations), Molecular Biology (5.3k citations), Cancer Research (998 citations), Reproductive Medicine (264 citations) and Immunology (563 citations). Niklas Schultz has collaborated with scholars based in Sweden, United Kingdom and Spain. Frequent co-authors include Thomas Helleday, Helen E. Bryant, Mark Meuth, Elena López‐Knowles, Suzanne Kyle, Nicola J. Curtin, Huw D. Thomas, Natalia Issaeva, Eva Petermann and Manuel Luís Orta. Their work appears in journals such as Nature Communications, Molecular and Cellular Biology, Journal of Molecular Biology, Nature and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.